The University of Western Australia and partners will deliver a clinical entrepreneur pilot program and targeted training to boost medical product commercialization, both funded by the MTPConnect Researcher Exchange and Development within Industry program.
MTPConnect, an organization created to accelerate the growth rate of the medical technology, biotechnology and pharmaceutical sector in Australia, has announced the initiatives.
Professor Kevin Pfleger, Director Biomedical Innovation at UWA, said the entrepreneur program will help equip healthcare professionals with the skills to translate and commercialize their ideas and innovation into impactful solutions.
The program will provide workshops and networking opportunities to healthcare professionals to develop innovative ideas into products, enterprises and businesses that benefit the clinical care of patients.
Wrays, one of the largest independent intellectual property specialist firms in Australia, has partnered with Yuuwa Capital, QRC Solutions and Biodesign Australia, administered by UWA.
The Wrays Consortium will deliver The Commercialization Framework Supporting Biomedical Outcomes, providing training and education programs to develop the skill sets required for the commercialization of therapeutic products and medical technologies.